Cancer Care Gap: Millions Left Behind in India

Cancer, once considered a death sentence, is now treatable for many due to advancements in early detection and personalized therapies. However, progress in oncology research has created significant disparities, with over half of global cancer deaths occurring in Low- to Upper-Middle Income Countries (LMICs) like India.

In India, rising cancer incidence is driven by aging populations and changing lifestyles, straining healthcare systems. Cervical cancer, though preventable, remains a leading cause of death for women due to low awareness and screening rates, particularly among lower socioeconomic groups. India's HPV vaccination campaign is a crucial step, but requires complementary screening and education.

Lifestyle factors such as tobacco and alcohol use contribute to various cancers in men. Addressing modifiable risks and implementing structured screening for common cancers are vital. The effectiveness of cancer care hinges not only on scientific innovation but also on robust healthcare delivery systems.

Local research from India is gaining international recognition, offering unique perspectives and challenging global norms. A clinical trial from Tata Memorial Hospital, Mumbai, demonstrated that ultra-low dose immunotherapy combined with oral chemotherapy significantly improved survival and reduced side effects for advanced head and neck cancer patients, highlighting the potential for affordable treatments in resource-constrained settings.